HIGHLIGHTS
- who: Daniela Di Carlo and colleagues from the Department of Women`s and Children`s Health, University of Padova, Padua, Italy have published the Article: Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma, in the Journal: (JOURNAL)
- what: The aim of this review is to draw together understanding of the biology of MYOD1L122R mutation and its frequency in tumors from patients affected by RMS and to explore clinical features of such patients, the prognostic role of MYOD1L122R mutation and the possible implications for risk stratification and treatment. The authors focused on clinical aspects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.